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BRIEF DEFINITIVE REPORT
        Recognition of pathogens by the innate immune 
system activates Toll-like receptor (TLR)-medi-
ated pathways, resulting in NF-    B  –  induced tran-
scription of infl   ammatory cytokines (  1  ). These 
molecules subsequently direct the initiation of ap-
propriate adaptive responses, leading ultimately to 
clearance or containment of the invading patho-
gen (  2  ). Due to their potent biological activity, 
however, inappropriately prolonged or excessive 
release of proinfl  ammatory mediators can result in 
deleterious eff  ects for the host. This is exempli-
fi  ed by the acute-phase cytokine IL-6, whose role 
in the development of the potentially pathogenic 
Th17 subset of T cells has recently been described 
(  3  ). Furthermore, therapies targeting the cyto-
kines IL-1, IL-6, and TNF-     have all shown 
promising effi   cacy in the treatment of autoim-
mune disorders, implying a central role for these 
molecules in disease pathogenesis (  4, 5  ). 
  Given the dual nature of proinfl  ammatory 
cytokines  —  essential for host defense but poten-
tially lethal in excessive quantities  —  the mam-
malian immune system has evolved numerous 
regulatory mechanisms to precisely control the 
magnitude and time course of infl  ammatory 
  responses (  6  ). Regulation occurs at various levels 
of TLR signaling, from receptor ligation to gene 
transcription (  7  ). Known mechanisms include 
the release of soluble TLRs (  8, 9  ), competition 
for adaptor molecules and signaling intermedi-
ates (  10  –  13  ), direct inhibition of NF-    B func-
tion ( 14, 15 ), and transcriptionally nonpermissive 
chromatin structure (  16  ). The multiple levels 
of regulation highlight the importance of these 
processes and allow for greater specifi  city in 
controlling individual components of the in-
fl  ammatory response. 
  The critical importance of balancing host 
defense with protection from infl  ammatory dis-
ease suggests that mutations strongly aff  ecting 
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  Although infl  ammatory cytokines produced by activation of Toll-like receptors (TLRs) are 
essential for early host defense against infection, they also mediate a vast array of pathol-
ogies, including autoimmune disease, hypersensitivity reactions, and sepsis. Thus, numerous 
regulatory mechanisms exist in parallel with proinfl  ammatory pathways to prevent exces-
sive release of these potent effector molecules. We report elucidation of a novel regulatory 
function for interleukin receptor  –  associated kinase (IRAK)-1 binding protein 1 (IRAK1BP1, 
also known as SIMPL) through quantitative trait locus mapping of the TLR response in 
wild-derived mouse strains. This gene emerged as a negative regulator of TLR2-mediated 
interleukin (IL)-6 production in MOLF/Ei mice, which expressed IRAK1BP1 mRNA in an 
allele-specifi  c manner when crossed with the C57BL/6J strain. Human peripheral blood 
mononuclear cells and primary macrophages from two other wild-derived mouse strains 
also induced IRAK1BP1 mRNA by 4 hours after stimulation with agonists of various TLRs. 
Examination of its effects on IL-6 and other cytokines demonstrated that IRAK1BP1 regu-
lates transcription of a specifi  c subset of TLR-responsive genes, producing an overall anti-
infl  ammatory profi  le. Our results reveal that IRAK1BP1 is a critical factor in preventing 
dangerous overproduction of proinfl  ammatory cytokines by the innate immune system and 
in infl  uencing the specifi  city of TLR responses. Furthermore, these results show that the 
genetic diversity of wild-derived mouse strains makes them a valuable model of important 
human gene functions that have been lost in some laboratory-inbred strains. 306 IRAK1BP1 REGULATES TLR RESPONSES | Conner et al.
and   Salmonella typhimurium   susceptibility (  20  ), as well as resis-
tance to lethal shock induced by TNF-     (  21  ). 
  We have observed that several wild-derived mouse strains 
have increased TLR-stimulated cytokine production com-
pared with classical inbred strains. In an ongoing quantitative 
trait locus (QTL) analysis to map the gene(s) underlying this 
phenotype, we have observed that the major locus conferring 
increased TLR-stimulated IL-6 production in the wild-de-
rived strain MOLF/Ei is partially compensated for by another 
locus, which inhibits infl  ammatory cytokine synthesis. The 
compensatory allele confers on several wild-derived strains the 
ability to induce mRNA synthesis of IL-1 receptor  –  associated 
kinase (IRAK)-1 binding protein 1 (IRAK1BP1), a gene pre-
viously implicated in TNF receptor signaling (  22, 23  ), after 
TLR responsiveness will be appropriately compensated through 
evolutionary selection. This scenario lends to the experimental 
use of evolutionarily distant mouse strains to elucidate novel 
regulatory gene functions. Among the     450 established in-
bred mouse strains, most descended from a restricted number 
of founder animals derived from the   Mus musculus   group 
of subspecies, and thus have rather limited genetic diversity. 
There are, however, several   Mus musculus   wild-derived inbred 
strains available, which have been captured and bred in geo-
graphically and temporally distinct circumstances. Such strains 
have large genomic contributions from other subspecies and are 
reported to have greater than one million years of evolution-
ary distance from classical inbred mice (  17, 18  ). This diversity 
has been successfully used to map traits such as fl  avivirus (  19  ) 
    Figure 1.         Phenotypic characterization and genetic mapping of TLR hyperresponsiveness in MOLF/Ei mice.   (A and B) Peritoneal macrophages were 
elicited from MOLF/Ei and C57BL/6J (B6) strains and stimulated with the TLR agonists indicated. Northern blot analysis was performed using probes specifi  c 
for TNF-    , IL-6 (A and B), and IL-10 (B). EtBr staining of 28s and 18s RNA was used as a loading control. (C) Macrophages from MOLF/Ei mice and the three 
classical strains shown were stimulated with 2     g/ml LTA for the indicated length of time, and IL-6 mRNA was assessed by quantitative RT-PCR. (D) Macro-
phages from C57BL/6J and three wild-derived strains were stimulated with 2     g/ml LTA for 6 h. Supernatants were assayed for IL-6 using ELISA. (E) F1 and 
C57BL/6J macrophages were stimulated with 2     g/ml LTA for the indicated times. IL-6 and TNF-     mRNA was assayed using quantitative PCR and Northern 
blot analysis. All phenotypic assays represent at least three independent experiments. (F) 82 C57BL/6JxF1 backcross mice were analyzed by ELISA for IL-6 
production 6 h after stimulation with 2     g/ml LTA (insert). QTL analysis of genome-wide microsatellite marker coverage for 41 mice revealed a 10 cM, 
positively acting locus on chromosome 6 named   Why1   and a 23 cM, negatively acting locus on chromosome 9 named   Why2  . The remaining 41 mice were 
genotyped at these loci to achieve LOD scores of statistical signifi  cance. (G) Linkage map of the   Why2   interval. Markers at the indicated positions were used 
for QTL analysis and are shown both as raw values and adjusted using the contribution of genotype at   Why1   for  background.   JEM VOL. 205, February 18, 2008  307
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MSM/Ms and Czech/EiII (  Fig. 1 D  ), again consistent with 
an intersubspecifi  c origin. 
  To examine the pattern of inheritance of TLR hyper-
responsiveness, Northern blot and quantitative RT-PCR 
analyses were performed using F1(C57BL/6JxMOLF/Ei) 
peritoneal macrophages. IL-6, but not TNF-    , was elevated 
in F1 compared with C57BL/6J macrophages after LTA 
stimulation (  Fig. 1 E  ). We thus chose LTA-stimulated IL-6 
production as a marker of TLR hyperresponsiveness to use 
in our mapping studies. To map genetic loci underlying the 
observed phenotype, 82 C57BL/6JxF1(C57BL/6JxMOLF/Ei) 
backcross mice were analyzed by ELISA for IL-6 secretion 
6 h after stimulation with LTA. Genome-wide microsatellite 
marker coverage for the initial 41 mice analyzed by QTL 
analysis revealed two loci on chromosomes 6 and 9, with 
suggestive linkage to the trait (  Fig. 1 E  ). These loci were 
named   wild-derived hyperresponse   (  Why  )  1   and   Why2  , respec-
tively. The remaining 41 mice were genotyped at these loci, 
and signifi  cant logarithm of the odds (LOD) scores of 3.69 
(  Why1  ) and 5.49 (  Why2  ) were obtained. Heterozygosity at 
  Why1   (D6MIT328) was concordant with the observation 
in parental strains and conferred a positive eff  ect on IL-6 
  secretion, whereas a partially compensating negative eff  ect 
was linked to heterozygosity at   Why2   (D9MIT155). Fur-
thermore, a signifi  cant epistatic interaction (LRS 48.1) was 
detected between the two loci. This interaction implies that 
both genes function in the same biological pathway, a fea-
ture commonly found between evolutionarily compensatory 
alleles (  24  ). 
stimulation of TLR2. In contrast to its previously proposed 
role, we fi  nd that IRAK1BP1 inhibits the transcription of in-
fl  ammatory cytokines from their endogenous promoters after 
TLR stimulation. 
    RESULTS AND DISCUSSION   
  TLR hyperresponsiveness in MOLF/Ei mice maps to two loci, 
one of which is inhibitory 
  Wild-derived strains of mice are separated from common 
laboratory strains by signifi  cant evolutionary distance, but are 
still able to breed with inbred strains and can thus be used in 
forward genetic analyses (  17  ). Accordingly, we screened the 
wild-derived strain MOLF/Ei against the classical strain 
C57BL/6J for cytokine responsiveness to various TLR family 
agonists. Peritoneal macrophages from MOLF/Ei mice ex-
hibited increased levels of cytokine mRNA after stimulation 
with the TLR2 agonist lipoteichoic acid (LTA), the TLR3 
agonist polyI:C, and the TLR4 agonist LPS (  Fig. 1, A and B  , 
and Fig. S1, which is available at http://www.jem.org/cgi/
content/full/jem.20071499/DC1).   The largest eff  ect was 
observed for LTA- and LPS-stimulated IL-6 production. 
To confi  rm that MOLF/Ei mice were hyperresponsive com-
pared with other classical inbred strains, we examined LTA-
induced IL-6 production in CBA and BALB/c mice. These 
strains responded similarly to C57BL/6J, suggesting that 
  intersubspecifi  c diff  erences (  18  ) rather than more recently 
introduced mutations underlie the phenotype (  Fig. 1 C  ). The 
trait was also observed at the level of secreted IL-6 measured 
by ELISA and was present in two other wild-derived strains, 
    Figure 2.           Cis  -acting regulatory elements confer TLR-mediated IRAK1BP1 inducibility in MOLF/Ei, but not C57BL/6J, macrophages.   (A)  Perito-
neal macrophages were stimulated with 2     g/ml LTA for the indicated length of time. IRAK1BP1 mRNA was detected by Northern hybridization and quanti-
tative PCR (each from independent experiments). (B) Macrophages elicited from F1(B6xMOLF) mice were stimulated with 2     g/ml LTA for the number of 
hours indicated in each box. cDNA was prepared and IRAK1BP1-specifi  c primers were used to amplify a 300-bp fragment containing a silent c  → t  mutation. 
Gel-purifi  ed products were sequenced to compare the amount of cDNA present from the MOLF/Ei (red peak) to C57BL/6J (blue peak) alleles. *, F1 genomic 
DNA. (C) Peritoneal macrophages from the indicated mouse strains were stimulated with 2     g/ml LTA for 2 or 4 h, and IRAK1BP1 mRNA was assessed by 
Northern blot hybridization. (D) Human PBMCs were stimulated with the indicated TLR agonists for 2 or 4 h. IRAK1BP1 mRNA was assayed by quantitative 
RT-PCR. Data shown are mean   ±   range from duplicate wells, representative of two independent experiments.     308 IRAK1BP1 REGULATES TLR RESPONSES | Conner et al.
    Cis  -acting regulatory elements on   Why2   confer TLR 
inducibility on IRAK1BP1 
  Although the genetically determined interval containing 
  Why2   was relatively large (23 cM;   Fig. 1 G  ), fi  ne mapping of 
quantitative traits is often extremely diffi   cult due to the ef-
fects of other loci with minor contributions to the pheno-
type. These undetected loci provide variability that prevents 
the use of single crossover events for defi  ning interval bound-
aries. Thus, we combined a gene microarray approach (Fig. 
S2 and Table S1, available at http://www.jem.org/cgi/
content/full/jem.20071499/DC1) with our mapping studies 
to identify potential candidate genes. Among genes diff  eren-
tially expressed in TLR-activated MOLF/Ei and C57BL/6J 
splenocytes from the   Why2   locus (  Table I  ),   Irak1bp1   stood 
out both for the magnitude of its expression diff  erence 
(    20-fold) and for its known role in infl  ammatory signaling.   
Furthermore, this gene  ’  s previously defi  ned ability to physi-
cally bind another IRAK family member, IRAK-1 (  23  ), made 
  These quantitative trait-mapping results indicate that the 
major underlying genetic basis of TLR hyperresponsiveness 
in MOLF/Ei mice is contained within the   Why1   interval. 
  Irak-2   is the only gene in this region with a known role in 
TLR signaling. Despite the presence of several polymorphisms 
between the MOLF/Ei and C57BL/6J   Irak-2   alleles, we have 
thus far been unable to link any of these diff  erences to the 
phenotype, though a serial outcross strategy has narrowed the 
interval even farther on either side of   Irak-2   (unpublished data). 
In addition to revealing the   Why1   locus, our mapping strategy 
also unveiled genetic mechanisms that wild-derived mouse 
strains have evolved to compensate for this trait and uncov-
ered   Why2   as a major negatively acting locus in MOLF/Ei 
mice. Although   Why2   clearly does not act strongly enough to 
mask the hyperresponsive phenotype observed in MOLF/Ei 
mice, we reasoned that a regulatory allele was likely preserved 
at this locus under selective pressure from the overall proin-
fl  ammatory bias conferred by   Why1  . 
    Table I.         Strain-specifi  c variation of gene expression in the vicinity of the   Why2   locus  
  Transcript   FC   Gene name    Genbank   position (Mb)    Annotation 
1452738_at 0.33 SLP-1; STORP; WPB72 AK007508 58051328 GO:5498(sterol carrier activity)
1443037_at 4.304 Sdfr1; AW554172, Nptn BB183534 58380545 GO:50839(cell adhesion molecule binding)
1458512_at 23.19 ESG; Grg3a; Tle3; mKIAA1547 AW490470 61171677 GO:16055(Wnt receptor signaling 
 pathway);  GO:7283(spermatogenesis); 
 GO:6350(transcription)
1421918_at 0.462 LANP; pp32; Anp32; PHAP1 AF022957 62139433 GO:5515(protein binding)
1442735_at 9.069 AZ-2; Sez15, Oaz2 BM941420 65474595 GO:5509(calcium ion binding)
1438246_at 3.178 9130020E21Rik BM201663 65707015 GO:16055(Wnt receptor signaling 
 pathway)
1420583_a_at 0.498 sg; ROR1; ROR2; ROR3; Nr1f1 NM_013646 68452965 GO:46068(cGMP metabolic process); 
  GO:43030(regulation of macrophage 
 activation);  GO:6350(transcription)
1460083_at 3.027 kuz; MADM; Adam10 
 1700031C13Rik
AW552781 70478342 GO:7220(Notch receptor processing); 
 GO:7267(cell-cell  signaling)
1421955_a_at 0.413 Nedd4a; Nedd4-1; AA959633 NM_010890 72460913 GO:6464(protein modifi  cation process); 
 GO:6512(ubiquitin  cycle)
1456329_at 2.419 A230098A12Rik, Prtg BB130087 72605779 GO:7155(cell adhesion)
1444411_at 5.932 d; Dbv; MVa; fl  r; Myo5; MyoVA;
 Sev-1
BB309795 74857810 GO:51643(ER localization); 
 GO:7268(synaptic  transmission); 
 GO:7601(visual  perception)
1436346_at 0.399 GARP; AI480638; CD109 AV246882 78401460 GO:48503(GPI anchor 
 binding);GO:17114(wide-spectrum 
  protease inhibitor activity)
1445387_at 4.754 Susp1; Senp6 mKIAA0797; 
 2810017C20Rik
BM118663 79852586 GO:6508(proteolysis); 
 GO:6512(ubiquitin  cycle)
1447762_x_at 3.749 AI314958; 2310047E01Rik, Car12 BB503164 66512885 GO:6730(one-carbon compound 
 metabolic  process)
1431771_a_at 0.0454 AIP70; Aabp3; SIMPL; AI851240; 
 IRAK1BP1
AK014712 82626716 GO:7249(I-    B kinase/NF-    B cascade)
1427153_at 0.358 Bckdhb AW047304 83745498 GO:9063(amino acid catabolic process)
1428547_at 0.409 NT; Nt5; eNT; CD73; AI447961 AV273591 88125532 GO:9166(nucleotide catabolic process)
Of the     560 genes present between 50 and 96 Mb on chromosome 9, 46 genes with a greater than twofold difference in expression levels between C57BL/6J and MOLF/Ei 
were identifi  ed. Genes that did not pass a standard expression threshold for either strain were discarded. The remaining 20 genes are listed in the order of their physical 
location on the chromosome. Average fold change (FC) indicates the ratio of expression levels in C57BL/6 relative to MOLF/Ei; the left column indicates Affymetrix accession 
number. Microarray data were deposited in the GEO database under accession numbers   GSM259766   and   GSM259767  .JEM VOL. 205, February 18, 2008  309
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to assess the general function of infl  ammatory regulators, 
the intricate nature of site-specifi  c chromatin remodeling 
and individual cytokine expression patterns is increasingly 
gaining appreciation (  25, 26  ). Furthermore, reporter assays 
are not able to reveal all trans-acting regulatory eff  ects that 
may be infl  uencing the actual amount of a specifi  c cytokine 
that is produced. 
  Given the complexity of cytokine gene regulation that is 
not incorporated into basic reporter assays, we sought to fi  rst 
characterize the eff  ect of IRAK1BP1 in a more functional 
model of TLR signaling. The RAW264.7 mouse macro-
phage cell line is responsive to TLR activation and synthe-
sizes cytokines from their endogenous genomic loci (  27  ). 
To examine the role of IRAK1BP1 in a fully functional TLR 
pathway, we generated stably overexpressing RAW264.7 
cells through retroviral transduction. IRAK1BP1-transduced 
cells produced significantly less IL-6 mRNA after LTA 
stimulation compared with empty vector  –  transduced cells. 
Furthermore, secreted IL-6 levels were decreased by     75% in 
IRAK1BP1-transduced cells (  Fig. 3 A  ).   Unexpectedly, in 
analyzing the levels of IRAK1BP1 mRNA in these cells, it 
was observed that RAW264.7 macrophages constitutively 
express high levels of transcript (Fig. S3, available at http://
www.jem.org/cgi/content/full/jem.20071499/DC1). There-
fore, we used a lentiviral-based short-hairpin RNA (shRNA) 
it an even more attractive candidate given the detected epistasis 
with the locus containing   Irak-2  . 
  To verify the microarray results in the conditions used 
during the mapping analysis, MOLF/Ei and C57BL/6J perito-
neal macrophages were stimulated with LTA, and IRAK1BP1 
mRNA was measured. Northern blotting revealed a signifi  -
cant increase in transcript level after LTA stimulation in 
MOLF/Ei, but not C57BL/6J, macrophages (  Fig. 2 A  ).   
To determine whether the observed TLR inducibility of 
IRAK1BP1 mRNA in MOLF/Ei macrophages was linked to 
the detected locus on chromosome 9, allelic imbalance tests 
were performed. In F1(C57BL/6JxMOLF/Ei) macrophages, 
IRAK1BP1 mRNA was present almost exclusively from the 
MOLF/Ei allele 3 h after LTA stimulation, demonstrating the 
presence of cis-acting polymorphisms that make the gene tran-
scriptionally responsive in MOLF/Ei mice (  Fig. 2 B  ). Thus, 
the ability to up-regulate IRAK1BP1 mRNA after TLR stim-
ulation is genetically linked to the inhibitory   Why2   locus de-
tected in the analysis of IL-6 hyperresponse. 
    Why2   was found in our mapping analysis as a compensat-
ing mutation in the presence of an overall hyperresponsive 
phenotype. We therefore reasoned that if IRAK1BP1 was 
responsible for the linkage to this region, two other wild-
derived strains with the same phenotype, Czech/EiII and 
MSM/Ms (  Fig. 1 D  ), would also be under selective pressure 
to induce expression of IRAK1BP1 in response to TLR 
stimulation. Northern blot analysis revealed that these strains 
up-regulate IRAK1BP1 mRNA after stimulation with LTA, 
whereas C57BL/6J and another classical inbred strain, A/J, 
were transcriptionally unresponsive (  Fig. 2 C  ). Macrophages 
in the quiescent state did not show high levels of IRAK1BP1 
mRNA in any of the fi  ve strains analyzed in   Fig. 2   (A and 
C), although previous data have shown basal expression lev-
els in other tissues (  23  ). We further extended our transcrip-
tional analysis of IRAK1BP1 to human PBMCs and showed 
that it was transcriptionally responsive to a variety of TLR 
agonists in these cells as well (  Fig. 2 D  ). Thus, IRAK1BP1 
may also function in the context of human TLR signaling 
biology, and this trait is well modeled in three wild-derived 
mouse strains. 
  IRAK1BP1 contributes to the effect of   Why2   
on LTA-induced IL-6 production 
  We next assessed the functional implication of   Irak1bp1   in-
ducibility from the   Why2   locus in the context of our genetic 
mapping data. Because the MOLF/Ei allele at the   Why2   
locus had an inhibitory eff  ect on IL-6 production, and 
IRAK1BP1 was up-regulated in MOLF/Ei but not C57BL/6J 
mice, we predicted that IRAK1BP1 would down-regulate 
TLR-stimulated IL-6 production in macrophages. Previous 
studies have implied that IRAK1BP1 functions in the con-
text of TNF-     signaling as a co-activator of RelA-medi-
ated transcription (  22, 23  ). However, these studies have 
been conducted using reporter plasmids, whereas our pheno-
type relied on measuring endogenously produced IL-6. Al-
though ectopically introduced reporter assays are often used 
    Figure 3.         IRAK1BP1 inhibits LTA-stimulated IL-6 production.  
(A) IRAK1BP1 was stably introduced into RAW264.7 macrophages using 
retroviral transduction. IRAK1BP1-overexpressing and empty vector  –
  transduced cells were stimulated with 2     g/ml LTA and IL-6 mRNA was 
quantifi  ed using RT-PCR at the indicated time. Secreted IL-6 was quanti-
fi  ed 16 h after stimulation using ELISA. (B) Stably transduced IRAK1BP1 
or control (nonhomologous) shRNA-expressing cells were assessed by 
quantitative PCR for levels of IRAK1BP1 mRNA (inset) along with un-
transduced RAW264.7 macrophages. All cell types were assayed for LTA-
stimulated IL-6 production as in A. The small variation between control 
shRNA and untransduced cell lines may represent residual effects of viral 
infection. Mean   ±   range from duplicate (RT-PCR) or   ±   SEM from triplicate 
(ELISA) wells are shown. RT-PCR experiments are representative of at 
least   n   = 3 independent experiments.     310 IRAK1BP1 REGULATES TLR RESPONSES | Conner et al.
pure population of transductants, we were still able to 
signifi  cantly impair the ability of MOLF/Ei and F1(C57BL/
6JxMOLF/Ei) peritoneal macrophages to induce IRAK1BP1. 
Furthermore, this inhibition directly aff  ected the pheno-
type of LTA-stimulated IL-6 secretion in MOLF/Ei and 
F1, but not C57BL/6J, macrophages, implying a strain-
specific effect on the phenotype (  Fig. 4 B  ). Finally, to di-
rectly demonstrate that IRAK1BP1 was contributing to 
the linkage of   Why2   to the trait, we chose a small panel of 
21 N2 mice from the mapping experiments to receive 
IRAK1BP1 shRNA. Introduction of this construct into 
peritoneal macrophages decreased the LOD score for this 
group of mice by 0.67 compared with introduction of 
control shRNA into cells from the same mice (  Fig. 4 C  ). 
Our inability to completely abolish linkage to   Why2   in the 
presence of IRAK1BP1 shRNA may be due to a low effi   -
ciency of transduction or incomplete knockdown, allow-
ing re  sidual contributions to persist. Nonetheless, these data 
demonstrate that inhibition of LTA-induced IRAK1BP1 ex-
pression decreases linkage to the   Why2   locus and implies a 
role for expression of this gene in the context of the over-
all phenotype. 
  IRAK1BP1 exhibits an antiinfl  ammatory regulatory profi  le 
at the transcriptional level 
  The unique transcriptional requirements of individual cyto-
kines are key mechanisms by which immune cells direct the 
nature of an infl  ammatory response. To characterize the breadth 
of cytokines aff  ected by IRAK1BP1, we used the ability of 
gene knockdown approach to confi  rm IRAK1BP1  ’  s inhibitory 
eff  ect on IL-6 production. Expression of IRAK1BP1 was 
  reduced   >  95% in knockdown cells compared with untrans-
duced RAW264.7 cells and those receiving a control shRNA 
construct with no homologous sequence in the mouse genome. 
Consistent with its inhibitory role, IRAK1BP1 knockdown 
potently increased both LTA-induced IL-6 mRNA and pro-
tein expression compared with control and untransduced cell 
lines (  Fig. 3 B  ). 
  We next sought to confi  rm the role of IRAK1BP1 in the 
observed linkage to the   Why2   interval (  Fig. 1, F and G  ) by 
examining its role in primary macrophages from the strains 
used in the mapping study. We used the ability of the lentivi-
ral shRNA system to infect primary mammalian cells as a 
means to inhibit LTA-inducible expression of IRAK1BP1 
from the MOLF/Ei allele. Transduction and selection for sta-
ble integration of the shRNA construct in bone marrow  – 
derived macrophages (BMDMs) from MOLF/Ei mice decreased 
the amount of IRAK1BP1 mRNA in these cells after LTA 
stimulation. Consistent with its eff  ect in RAW264.7 cells and 
the mapping data, inhibition of IRAK1BP1 in MOLF/Ei 
BMDMs reduced IL-6 mRNA and protein levels after TLR 
activation (  Fig. 4 A  ).   
  To assess the allelic specifi  city of IRAK1BP1  ’  s eff  ect di-
rectly on the phenotype used in the mapping of   Why2  , we 
introduced the shRNA construct into both MOLF/Ei and 
C57BL/6J peritoneal macrophages. Although these cells 
are terminally diff  erentiated and nondividing, thus decreas-
ing effi     ciency of infection and preventing selection of a 
    Figure 4.         IRAK1BP1 regulates the LTA-stimulated IL-6 phenotype in primary MOLF/Ei macrophages and contributes to the linkage of the 
  Why2   locus.   (A) BMDMs were infected with IRAK1BP1 or nonhomologous control shRNA constructs during in vitro differentiation. Stable transduc-
tants were selected and assessed for IRAK1BP1 mRNA, IL-6 mRNA, and protein after stimulation with LTA. IL-6 protein levels were assessed at 6 h after 
stimulation. (B) Peritoneal macrophages from the indicated strains were infected with control or IRAK1BP1 shRNA and assayed for LTA-induced 
IRAK1BP1 (inset) or IL-6 production 6 h after stimulation. Data representative of two (A) or three (B) independent experiments. (C) Macrophages from 
21 N2(C57BL/6JxF1) mice were transduced with IRAK1BP1 and control shRNA (three wells each construct per mouse) and assessed for LTA-stimulated 
IL-6 secretion. Linkage to D9MIT155 (  Why2  ) was calculated for each condition using a QTL analysis.     JEM VOL. 205, February 18, 2008  311
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to transcribe the proinfl  ammatory cytokines IL-12p40 and 
RANTES (CCL5). However, no eff  ect was observed on the 
ability to transcribe TNF-    . As TNF-     is known to be an 
  “  early response  ”   cytokine (  25  ), we confi  rmed that IRAK1BP1 
was not mediating eff  ects before the time points used in our 
RAW264.7 macrophages to activate transcription of endoge-
nous TLR-responsive genes, using all of the subtle modifi  ca-
tions required at each regulatory region. As shown in   Fig. 5   
(A and B), shRNA and overexpression studies demonstrated that 
IRAK1BP1 inhibits the ability of LTA-stimulated macrophages 
    Figure 5.         IRAK1BP1 regulates a subset of TLR-responsive genes and functions at the level of transcription.   (A and B) IRAK1BP1-overexpressing 
or knockdown RAW264.7 macrophages were stimulated with 2     g/ml LTA and assayed by quantitative RT-PCR for IL-12p40, TNF-    , and RANTES at the 
indicated times. Mean   ±   range for duplicate wells is shown, representative of at least two independent experiments. (C) Untransduced or shRNA-express-
ing cells were stimulated for the indicated lengths of time with 2     g/ml LTA. RNA was hybridized with the indicated cytokines in an RNase protection 
assay, using L32 and GAPDH as loading controls. (D) Nuclei were extracted from empty vector  –  transduced or IRAK1BP1-overexpressing cells, and IL-6, 
IL-10, and    -actin – specifi  c plasmids were used for nuclear runoff assays. (E) C57BL/6J MEFs were lentivirally transduced with IRAK1BP1 overexpressing 
of empty vector (pLEX) control constructs and stimulated with the indicated agonists for 1 (all agonists) or 2 (TNF-    , as indicated) h. IL-6 mRNA was as-
sessed by quantitative RT-PCR.     312 IRAK1BP1 REGULATES TLR RESPONSES | Conner et al.
  “  molecular switch,  ”   activating gene transcription from some 
promoters while inhibiting others. The importance of a bal-
anced and precisely coordinated infl  ammatory response is 
  increasingly recognized for its contribution to immune-mediated 
disease. As greater numbers of diagnostic and therapeutic 
techniques rely on specifi  c biological activities, the regula-
tory function of IRAK1BP1 in TLR-mediated infl  ammation 
described here extends our understanding of how these pro-
cesses are controlled. 
  MATERIALS AND METHODS 
  Genetic analysis.     Parental mouse strains were obtained from The Jackson 
Laboratory. Peritoneal macrophages were elicited from N2 mice and pheno-
typed as described below, and genome-wide scanning was performed ac-
cording to standard procedures, using two to three known polymorphic 
microsatellite markers per chromosome. Both genotypic and phenotypic 
data were analyzed using QTX software for genetic mapping of quantitative 
trait loci. 21 of the N2 mice used in the screen were also phenotyped after 
transduction with the pLKO.1 knockdown construct (described below), and 
linkage was assessed using the same methods. All experiments with mice 
were performed in accordance with the regulations and with the approval of 
Tufts/New England Medical Center Institutional Animal Care and Use 
Committee. All mice were maintained in a pathogen-free mouse facility at 
Tufts University School of Medicine. 
  Cell culture.     Primary mouse macrophages were elicited by intraperitoneal 
injection of 3% thioglycollate in 6  –  8-wk-old mice. 3 d later, the peritoneal 
cavity was washed with PBS, cells were resuspended in DMEM, 10% FBS, 
and plated. Assays were performed 6  –  16 h after plating or cells were trans-
duced for 24 h as described below. Bone marrow macrophages were isolated 
from femurs of 6  –  8-wk-old MOLF/Ei mice as described previously (  28  ). 
MEFs were isolated from 14-d embryos by trypsinization after dissection of 
the head and fetal liver. All experiments with MEFs were performed be-
tween passages two and fi  ve. Human PBMCs were obtained from healthy 
anonymous donors and were used with approval of the Institutional Review 
Board at Tufts University School of Medicine. PBMCs were prepared by 
Ficoll-Hypaque centrifugation on a Lymphoprep gradient. Cells were plated 
and stimulated with TLR agonists 6 h after plating. All cell lines were 
  obtained from American Type Culture Collection (ATCC) and grown in 
DMEM, 10% FBS. 
  Plasmids.     IRAK1BP1 cDNA was reverse transcribed and amplifi  ed from 
RAW264.7 RNA and cloned into the BamHI restriction site of the PINCO 
vector (provided by G. Nolan, Stanford University, Stanford, CA) (  29  ) for 
transduction of RAW264.7 or pLEX (Open Biosystems) for transduction of 
MEFs. Orientation of the insert was verifi  ed by sequencing. All shRNAs 
were expressed in the pKLO.1 vector and obtained from Open Biosystems. 
Plasmid DNA for psPAX2 and pMD2.G vectors was from Addgene. 
  Transfections and transductions.     The PINCO retroviral system was 
used as described previously (  29  ). Viral supernatants were harvested from 
PHOENIX-AMPHO HEK293 cells (ATCC) 3 d after transfection (Fugene; 
Roche) and added to dividing RAW264.7 cells for 24 h. 3 d later, transductants 
were selected by FACS for GFP expression. shRNA was expressed in the 
pLKO.1 plasmid (Open Biosystems). Viral supernatants were generated by 
transfecting 293-T cells with the shRNA construct and packaging vectors 
pSPAX2 and pMD2.G (Addgene). Stably expressing RAW264.7 knockdown 
clones were selected by growth in puromycin for 2 wk. BMDMs were infected 
with the pLKO.1 shRNA construct for 24 h on day 4 of maturation. Cells were 
washed twice with RPMI, 10% FBS, and were further matured in 3     g/ml 
puromycin for 3 d. Peritoneal macrophages were infected 3 h after elicitation 
for a 24-h period. Cells were washed twice with DMEM, 10% FBS, and re-
covered for 48 h before assays were performed. MEFs were transduced with 
IRAK1BP1 using the pLEX retroviral vector packaged using pSPAX2 
assay by assessing mRNA levels at 30, 60, and 90 min after 
stimulation with LTA and still observed no signifi  cant diff  er-
ence in mRNA levels between control and IRAK1BP1-over-
expressing or knockdown cell lines (Fig. S4, available at 
http://www.jem.org/cgi/content/full/jem.20071499/DC1). 
To further expand the panel of proinfl  ammatory cytokines af-
fected by IRAK1BP1, we conducted RNase protection assays 
using untransduced and stably expressing control shRNA and 
IRAK1BP1 shRNA RAW264.7 cells after stimulation with 
LTA. In addition to confi  rming the presence of an eff  ect for 
RANTES and the lack of an eff  ect for TNF-    , these results 
showed that IRAK1BP1 also inhibits the mRNA accumulation 
of IL-1    , IL-1    , and to a lesser degree MIP-1    , whereas exert-
ing only a minimal eff  ect on IP-10 (  Fig. 5 C  ). 
  The observed diff  erences in mRNA levels for the cyto-
kines described could be due to transcriptional inhibition 
or to an increase in the rate of mRNA degradation mediated 
by IRAK1BP1. To discriminate between these scenarios, a 
nuclear runoff   assay was performed for IL-6 in IRAK1BP1-
overexpressing or empty vector  –  transduced cell lines. At 
6 h after stimulation with LTA, IRAK1BP1-overexpressing 
RAW264.7 cells had noticeably less IL-6  –  nascent transcript, 
indicating that IRAK1BP1 exerts its eff  ect at a stage preced-
ing the transcription of infl  ammatory cytokines rather than 
through posttranscriptional regulatory mechanisms (  Fig. 5 D  ). 
Finally, we sought to determine whether IRAK1BP1 acts at 
the level of proximal signaling events specifi  c for TLR path-
ways or has a more general inhibitory role in infl  ammatory 
gene transcription. To address this question, mouse embry-
onic fi  broblasts (MEFs) from C57BL/6J mice were transduced 
with IRAK1BP1 or empty vector controls and stimulated 
with IL-1    , TNF-    , or various TLR agonists. Although 
varying degrees of inhibition were observed, all agonists con-
sistently exhibited decreased IL-6 production in the presence 
of overexpressed IRAK1BP1 (  Fig. 5 E  ). Collectively, these 
studies show that the presence of IRAK1BP1 has an overall 
transcriptionally inhibitory eff  ect on a subset of proinfl  amma-
tory cytokines that is exerted in the presence of several receptor 
signaling pathways.   
  Conclusion 
  We have used QTL analysis of LTA-stimulated IL-6 produc-
tion in wild-derived mice combined with microarray studies 
to elucidate a novel antiinfl  ammatory function of IRAK1BP1. 
The ability of IRAK1BP1 to inhibit infl  ammatory cytokine 
production was demonstrated using ectopic expression as 
well as shRNA knockdown of IRAK1BP1 in a mouse mac-
rophage cell line, two types of primary mouse macrophages, 
and MEFs. Although previous studies have examined this 
gene in the context of TNF-      –  stimulated RelA co-activa-
tion, the functional data presented here are the fi  rst to show 
its eff  ects on specifi  c cytokines transcribed from their endog-
enous loci. IRAK1BP1 could be mediating its eff  ects in a 
trans fashion by preferentially activating antiinfl  ammatory 
NF-    B  –  dependent genes, which subsequently repress in-
fl  ammatory cytokines. Alternatively, it could function as a JEM VOL. 205, February 18, 2008  313
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and pMD2.G as described above, and stable transductants were selected in 
5     g/ml puromycin. 
  Phenotypic analyses.     Salmonella minnesota Re595 LPS was purchased 
from Qbiogene. Poly I:C was obtained from GE Healthcare. All other ago-
nists were obtained from InvivoGen. After stimulation, supernatants were 
analyzed using IL-6 ELISA (R  &  D Biosystems), and mRNA was prepared 
with Trizol (Invitrogen). mRNA was subsequently analyzed by Northern 
blot hybridization, RNase protection (BD Biosciences), or quantitative RT-
PCR using Taqman gene-specifi  c probes (Applied Biosystems). 
  DNA sequencing and cDNA synthesis.     PCR products were amplifi  ed 
from genomic DNA or cDNA. Fragments were sequenced bidirectionally 
with internal primers. cDNA was synthesized from purifi  ed RNA (Trizol) 
using either random nanomer or oligo-dT primers and M-MLV reverse 
transcription (New England Biolabs, Inc.). 
  Nuclear runoff   assay.     Nuclei were isolated in Tween lysis buff  er after 6 h 
of stimulation of cells with LTA. If not used immediately for transcription, 
nuclei were frozen in liquid nitrogen. 200   μ  l of nuclei suspension in 1  ×   run-
off   buff  er (25 mM Tris-HCl, pH 8, 12.5 mM MgCl2, 750 mM KCl, and 
1.25 mM each of ATP, CTP, and GTP), 2   μ  l of RNase inihibitors (1 U/ml; 
New England Biolabs, Inc.), 200 mCi of a-[  32  P]UTP, and 3,000 Ci/mmol 
(PerkinElmer) were added to 220 liters of nuclei suspension and incubated at 
30  °  C for 30 min. Elongated transcripts were then isolated with Trizol, de-
naturated at 65  °  C for 5 min, and hybridized at 42  °  C for 48 h to 5   μ  g of de-
natured DNA immobilized on nylon fi  lters in a few milliliters of hybridization 
solution (200 mM NaHPO4, pH 7.2, 1 mM EDTA, pH 8, SDS 7%, deion-
ized formamide 45%, 250 mg/ml   Escherichia coli   tRNA). Filters were then 
washed once or twice at 37  °  C for 20  –  30 min in 40 mM NaHPO4-SDS 1% 
and exposed for autoradiography. 
  RNase protection assay.     Total cellular RNA from individual samples was 
isolated with Trizol and hybridized for 16 h with custom-designed probes 
(BD Biosciences) according to the manufacturer  ’  s instructions. Nonhybrid-
ized RNA was digested with RNase, and remaining hybrids were run on a 
5% PAAG gel together with probe. The gel was dried and exposed for 30 min 
to x-ray fi  lm. 
  Online supplemental material.     Fig. S1 shows an extended panel of cyto-
kine diff  erences in C57BL/6J and MOLF/Ei. Fig. S2 depicts the microarray 
data discussed. Fig. S3 shows constitutive expression of IRAK1BP1 mRNA in 
RAW264.7 cells. Fig. S4 shows no eff  ect of IRAK1BP1 on TNF-     produc-
tion at early time points after LTA stimulation. Table S1 shows genome-wide 
results from the microarray experiment. The online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20071499/DC1. 
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